You are here: Industry Insights > SDA

News List

Changes in Chinese regulations stimulate market for CRO biospectrumasia
September 13, 2018
This announcement is especially beneficial for Contract Research Organizations (CROs) like Accutest which have an early mover advantage in the Chinese market.
SDA to Accelerate the Review and Approval of 48 Overseas Marketed Drugs 1°C
August 21, 2018
Novartis will benefit the most, and Chinese pharmaceutical enterprises need to be encouraged as well
SDA to Speed Up the New Drug R&D: Clinical Trials Can be Conducted within 60 Days without being Negated or Questioned Yuntian
August 07, 2018
The State Drug Administration of China (SDA) has recently released the Announcement on Adjusting the Review and Approval
Gaining the Initiative! SDA Becoming an ICH “Administrator” Muzi
June 27, 2018
In the 2018 first meeting of ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) held in Kobe, Japan, SDA was absorbed as a member of ICH Management Committee.
Pains of TCM Injections, and Imminent Reevaluation of TCM Injections zhulikou431
June 15, 2018
The State Drug Administration of China (SDA) announced in the evening of May 29, 2018 the decision to revise the package insert of Bupleurum injection (as shown in the following figure).
Made in China—Albuvirtide, the World’s First Long-acting Anti-AIDS Drug, is Approved for Marketing Caicai
June 07, 2018
According to the information on the website of the State Drug Administration of China (SDA) on May 23
Even Reported by CCTV! The TCM Industry may be Reshuffled in China Yuntian
May 23, 2018
China has given unprecedented support in the TCM (traditional Chinese medicine) and successively introduced many policy documents conductive to the TCM development in recent years.